Margin compression challenges growth across firms, as strong top-line growth often comes with declining profitability, creating tension between growth potential and near-term risks.
The Witcher Season 4 divides fans with its adaptation choices, including a controversial Vesemir death and the introduction of new characters like Regis and Leo Bonhart.
Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
Margin compression challenges growth across firms, as strong top-line growth often comes with declining profitability, creating tension between growth potential and near-term risks.
The Witcher Season 4 divides fans with its adaptation choices, including a controversial Vesemir death and the introduction of new characters like Regis and Leo Bonhart.
Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.